Regeneron Pharmaceuticals (REGN) has moved into the #140 slot in the S&P 500 by market capitalization, displacing Emerson Electric Co. (EMR), according to The Online Investor. This is a routine market-cap ranking change with minimal immediate market impact beyond potential small index/ETF reweighting flows for funds that track the S&P 500.
Regeneron Pharmaceuticals (REGN) has moved into the #140 slot in the S&P 500 by market capitalization, displacing Emerson Electric Co. (EMR), according to The Online Investor. This is a routine market-cap ranking change with minimal immediate market impact beyond potential small index/ETF reweighting flows for funds that track the S&P 500.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
